Dr J. Allen Meadows Discusses Adherence to Biologics for Asthma

October 31st 2020, 12:30pm


Despite the price, adherence to biologics for asthma is usually good because of the effectiveness, said J. Allen Meadows, MD, president of the American College of Allergy, Asthma & Immunology.

Dr Milena Murray on the Importance of Using People-First Language With Patients Living With HIV

October 30th 2020, 6:00pm


The patients must always come first, emphasized Milena Murray, PharmD, MSc, BCIDP, AAHIVP, associate professor at Midwestern University College of Pharmacy, who practices at the Northwestern Medicine Infectious Disease Center in Chicago.

Weighing the Pros, Cons of At-Home Use of Biologics for Asthma

October 28th 2020, 7:30pm


When the first biologic to treat asthma was approved by the FDA in 2003, it needed to be administered subcutaneously in the physician’s office. Now, there are 3 options available for at-home use: mepolizumab, benralizumab, and dupilumab.

Enthesitis in Psoriatic Arthritis Increases Disease Burden, Decreases Treatment Satisfaction

October 27th 2020, 9:45pm


Patients with psoriatic arthritis with enthesitis are more likely to have severe disease than patients without enthesitis, and they and their physicians are less likely to be satisfied with their treatments.

Prescribing Patterns for Second-Line Treatment of Rheumatoid Arthritis

October 23rd 2020, 8:35pm


Despite the benefits of switching to a different mode of action in the second line, almost half of patients with rheumatoid arthritis were cycled to a second tumor necrosis factor inhibitor.

Diagnosing ARDS Earlier and the Development of ICU Delirium in Patients With ARDS

October 21st 2020, 4:37pm


Abstracts presented at CHEST 2020 looked at improving diagnosis of acute respiratory distress syndrome (ARDS) with machine learning and the development of intensive care unit delirium in hospitalized patients with ARDS.

Dr J. Allen Meadows on Making the Decision to Put a Patient With Asthma on a Biologic

October 14th 2020, 4:45pm


Patients with severe asthma are good candidates for biologics, but choosing which biologic requires a shared decision-making conversation, said J. Allen Meadows, MD, president of the American College of Allergy, Asthma & Immunology.

“Can You Hear Me Now?”: Postoperative Patient-Initiated Communication With Providers

October 14th 2020, 4:00pm


Patient-provider communication after surgery is critical for patient safety. The growth of patient-provider communication technologies has created opportunities to study postoperative patient-initiated communication.

Dialysis Is on the Ballot Again in California

October 14th 2020, 12:45pm


For-profit dialysis centers are spending heavily to defeat the measure.

Dr John Corboy Forecasts Promising Developments in Multiple Sclerosis

October 13th 2020, 12:00pm


Rebooting the immune system is an exciting approach, noted John Corboy, MD, professor of neurology, University of Colorado Denver, School of Medicine, and co-director of the Rocky Mountain MS Center at Anschutz Medical Campus.